269 related articles for article (PubMed ID: 25193444)
1. Outcome of occult uterine leiomyosarcoma after surgery for presumed uterine fibroids: a systematic review.
Pritts EA; Parker WH; Brown J; Olive DL
J Minim Invasive Gynecol; 2015 Jan; 22(1):26-33. PubMed ID: 25193444
[TBL] [Abstract][Full Text] [Related]
2. Risk of morcellation of uterine leiomyosarcomas in laparoscopic supracervical hysterectomy and laparoscopic myomectomy, a retrospective trial including 4791 women.
Lieng M; Berner E; Busund B
J Minim Invasive Gynecol; 2015; 22(3):410-4. PubMed ID: 25460521
[TBL] [Abstract][Full Text] [Related]
3. Occult Leiomyosarcomas in a Canadian Province: A Retrospective Cohort Study.
Wu CQ; Woo LY; Giede KC; Thiel J; Karreman E; Rattray DD
J Obstet Gynaecol Can; 2019 Jan; 41(1):46-51. PubMed ID: 30341020
[TBL] [Abstract][Full Text] [Related]
4. Assessing the risk of laparoscopic morcellation of occult uterine sarcomas during hysterectomy and myomectomy: Literature review and the ISGE recommendations.
Sizzi O; Manganaro L; Rossetti A; Saldari M; Florio G; Loddo A; Zurawin R; van Herendael B; Djokovic D
Eur J Obstet Gynecol Reprod Biol; 2018 Jan; 220():30-38. PubMed ID: 29149644
[TBL] [Abstract][Full Text] [Related]
5. ACOG Committee Opinion No. 770: Uterine Morcellation for Presumed Leiomyomas.
Obstet Gynecol; 2019 Mar; 133(3):e238-e248. PubMed ID: 30801477
[TBL] [Abstract][Full Text] [Related]
6. Risk of Undetected Cancer at the Time of Laparoscopic Supracervical Hysterectomy and Laparoscopic Myomectomy: Implications for the Use of Power Morcellation.
Perkins RB; Handal-Orefice R; Hanchate AD; Lin M; Paasche-Orlow MK
Womens Health Issues; 2016; 26(1):21-6. PubMed ID: 26701205
[TBL] [Abstract][Full Text] [Related]
7. The Morcellation Debate: The History and the Science.
Adelman MR
Clin Obstet Gynecol; 2015 Dec; 58(4):710-7. PubMed ID: 26512438
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of occult leiomyosarcomas and atypical leiomyomas after laparoscopic morcellation of leiomyomas in reproductive-age women.
Pados G; Tsolakidis D; Theodoulidis V; Makedos A; Zaramboukas T; Tarlatzis B
Hum Reprod; 2017 Oct; 32(10):2036-2041. PubMed ID: 28938732
[TBL] [Abstract][Full Text] [Related]
9. What is the Future of Open Intraperitoneal Power-Morcellation of Fibroids?
Parker WH; Pritts EA; Olive DL
Clin Obstet Gynecol; 2016 Mar; 59(1):73-84. PubMed ID: 26670834
[TBL] [Abstract][Full Text] [Related]
10. Occult Uterine Sarcoma and Leiomyosarcoma: Incidence of and Survival Associated With Morcellation.
Raine-Bennett T; Tucker LY; Zaritsky E; Littell RD; Palen T; Neugebauer R; Axtell A; Schultze PM; Kronbach DW; Embry-Schubert J; Sundang A; Bischoff K; Compton-Phillips AL; Lentz SE
Obstet Gynecol; 2016 Jan; 127(1):29-39. PubMed ID: 26646120
[TBL] [Abstract][Full Text] [Related]
11. Laparoscopic myomectomy and morcellation: A review of techniques, outcomes, and practice guidelines.
Glaser LM; Friedman J; Tsai S; Chaudhari A; Milad M
Best Pract Res Clin Obstet Gynaecol; 2018 Jan; 46():99-112. PubMed ID: 29078975
[TBL] [Abstract][Full Text] [Related]
12. Occult uterine leiomyosarcoma in women undergoing abdominal and minimally invasive surgeries for myomas.
Ludwin A; Gawron I; Pityński K
Ginekol Pol; 2018; 89(10):546-552. PubMed ID: 30393842
[TBL] [Abstract][Full Text] [Related]
13. Uterine Morcellation for Presumed Leiomyomas: ACOG Committee Opinion, Number 822.
Obstet Gynecol; 2021 Mar; 137(3):e63-e74. PubMed ID: 33595252
[TBL] [Abstract][Full Text] [Related]
14. ACOG Committee Opinion No. 770 Summary: Uterine Morcellation for Presumed Leiomyomas.
Obstet Gynecol; 2019 Mar; 133(3):604-605. PubMed ID: 30801469
[TBL] [Abstract][Full Text] [Related]
15. Google searches and medical publication trends since the 2014 US Food and Drug Administration position on power morcellation: Do these translate into patient awareness?
Liou NS; Mallick R; Aref-Adib M; Odejinmi F
Eur J Obstet Gynecol Reprod Biol; 2019 Dec; 243():168-172. PubMed ID: 31715456
[TBL] [Abstract][Full Text] [Related]
16. Use of Electric Power Morcellation and Prevalence of Underlying Cancer in Women Who Undergo Myomectomy.
Wright JD; Tergas AI; Cui R; Burke WM; Hou JY; Ananth CV; Chen L; Richards C; Neugut AI; Hershman DL
JAMA Oncol; 2015 Apr; 1(1):69-77. PubMed ID: 26182307
[TBL] [Abstract][Full Text] [Related]
17. Risk of Occult Uterine Sarcoma in Presumed Uterine Fibroids.
Cui RR; Wright JD
Clin Obstet Gynecol; 2016 Mar; 59(1):103-18. PubMed ID: 26645385
[TBL] [Abstract][Full Text] [Related]
18. A Multicentre Retrospective Review of Clinical Characteristics of Uterine Sarcoma.
Wais M; Tepperman E; Bernardini MQ; Gien LT; Jimenez W; Murji A
J Obstet Gynaecol Can; 2017 Aug; 39(8):652-658. PubMed ID: 28729098
[TBL] [Abstract][Full Text] [Related]
19. Power morcellation-induced dissemination of sarcomatous component arising in leiomyoma.
Emoto I; Moriuchi K; Kanbayashi S; Inohaya A; Ri Y; Sato Y
J Obstet Gynaecol Res; 2018 Sep; 44(9):1843-1849. PubMed ID: 29974551
[TBL] [Abstract][Full Text] [Related]
20. Association Between Power Morcellation and Mortality in Women With Unexpected Uterine Cancer Undergoing Hysterectomy or Myomectomy.
Xu X; Lin H; Wright JD; Gross CP; Boscoe FP; Hutchison LM; Schwartz PE; Desai VB
J Clin Oncol; 2019 Dec; 37(35):3412-3424. PubMed ID: 31518176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
